{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:58:05Z","timestamp":1773914285329,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,15]]},"DOI":"10.1093\/cid\/cis919","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T06:08:31Z","timestamp":1350972511000},"page":"870-879","source":"Crossref","is-referenced-by-count":38,"title":["Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study"],"prefix":"10.1093","volume":"56","author":[{"given":"Helen","family":"Kovari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A.","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ledergerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Ryom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe W.","family":"Worm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Fontas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Morlat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,10,22]]},"reference":[{"key":"key\n\t\t\t\t20170623053424_CIS919C1","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170623053424_CIS919C2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","article-title":"Changes in causes of death among adults infected by HIV between 2000 and 2005: The \u201cMortalite 2000 and 2005\u201d surveys (ANRS EN19 and Mortavic)","volume":"48","author":"Lewden","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623053424_CIS919C3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1468-1293.2008.00686.x","article-title":"Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19)","volume":"10","author":"Rosenthal","year":"2009","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170623053424_CIS919C4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833a0918","article-title":"Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study","volume":"24","author":"Smith","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623053424_CIS919C5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/COH.0b013e3283473405","article-title":"Influence of antiretroviral therapy on liver disease","volume":"6","author":"Kovari","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20170623053424_CIS919C6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/01.aids.0000194799.43799.ea","article-title":"Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?","volume":"19","author":"Mocroft","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623053424_CIS919C7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/135965350701200808","article-title":"Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification","volume":"12","author":"Keiser","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170623053424_CIS919C8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/649922","article-title":"Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection","volume":"50","author":"Kovari","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.qai.0000221683.44940.62","article-title":"Severe liver disease associated with prolonged exposure to antiretroviral drugs","volume":"42","author":"Maida","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623053424_CIS919C10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/603559","article-title":"Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study","volume":"49","author":"Kovari","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/505495","article-title":"Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients","volume":"43","author":"McGovern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.22665","article-title":"Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy","volume":"49","author":"Ingiliz","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170623053424_CIS919C14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623053424_CIS919C15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","article-title":"The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology","volume":"22","author":"Kowalska","year":"2011","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20170623053424_CIS919C16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/QAD.0b013e3283389e26","article-title":"Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings","volume":"24","author":"Vispo","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623053424_CIS919C17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/cir306","article-title":"All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population","volume":"53","author":"El-Kamary","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAD.0b013e3280119e47","article-title":"Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients","volume":"21","author":"Mallet","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623053424_CIS919C20","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/j.1572-0241.2007.01428.x","article-title":"Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV","volume":"102","author":"Schiano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170623053424_CIS919C21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.cgh.2008.04.023","article-title":"Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection","volume":"6","author":"Saifee","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170623053424_CIS919C22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/ajg.2009.165","article-title":"Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy","volume":"104","author":"Chang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170623053424_CIS919C23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature","volume":"34","author":"Falco","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3851\/IMP1739","article-title":"Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis","volume":"16","author":"Arenas-Pinto","year":"2011","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170623053424_CIS919C25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/428093","article-title":"Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects","volume":"191","author":"Sanne","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623053424_CIS919C26","doi-asserted-by":"crossref","first-page":"e9183","DOI":"10.1371\/journal.pone.0009183","article-title":"Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa","volume":"5","author":"Chu","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170623053424_CIS919C27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.qai.0000243121.44659.a4","article-title":"Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection","volume":"43","author":"Chander","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623053424_CIS919C28","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/01.mlr.0000228003.08925.8c","article-title":"Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies","volume":"44","author":"Justice","year":"2006","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170623053424_CIS919C29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/QAI.0b013e318142aabb","article-title":"Alcohol consumption and HIV disease progression","volume":"46","author":"Samet","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623053424_CIS919C30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/135965350901400303","article-title":"Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study","volume":"14","author":"Conen","year":"2009","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170623053424_CIS919C31","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/QAD.0b013e32832e9b78","article-title":"Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy","volume":"23","author":"Marin","year":"2009","journal-title":"AIDS"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/6\/870\/17851305\/cis919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:38:07Z","timestamp":1714495087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,22]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,10,22]]},"published-print":{"date-parts":[[2013,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis919","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,22]]}}}